Feature

Poll: Medicare-for-all sees slight drop in support


 

Public support for a Medicare-for-all fell slightly between April and July, according to surveys by the Kaiser Family Foundation.

Support for a Medicare-for-all plan by party identification

The two polls showed that Americans’ overall favorability for a national Medicare-for-all plan declined from 56% in April to 51% in July. That drop came from Democratic respondents, whose support went from 80% to 72%, and from Republicans, whose support declined from 27% to 15%. Overall favorability increased from 52% to 55% among independents, Kaiser reported in its latest Health Tracking Poll.

“The small dip in Medicare-for-all support may reflect recent debate over the role of private insurance, including employer-sponsored coverage, which would largely disappear under the leading Medicare-for-all plans but would continue under a public option,” Kaiser said in a statement accompanying the report.

When given a choice, 55% of Democrats and Democratic-leaning Independents (Republicans were not asked) would rather build on the existing Affordable Care Act, compared with 39% who want to replace it with Medicare-for-all, the Kaiser investigators said.

Support is currently greater for a public option that would give all residents the ability to choose a government-sponsored insurance plan. Almost two-thirds of those surveyed said that they favor such a proposal, with support at 85% for Democrats, 68% for independents, and 36% for Republicans, the report’s authors said.

The two polls were conducted among 1,196 adults during July 18-23, 2019, and 1,203 adults during April 11-16, 2019. The margin of sampling error for both polls was plus or minus 3 percentage points.

Recommended Reading

A personal touch can be key to state-level advocacy
MDedge Hematology and Oncology
ASTRO announces new president-elect, board members
MDedge Hematology and Oncology
Dr. Alexa will see you now: Is Amazon primed to come to your rescue?
MDedge Hematology and Oncology
CMS proposes improved E/M payments, additional price transparency for hospitals
MDedge Hematology and Oncology
Mayo Clinic takes honors as top hospital
MDedge Hematology and Oncology
CMS is proposing higher payments for E/M visits
MDedge Hematology and Oncology
CMS plans to give MIPS an overhaul
MDedge Hematology and Oncology
Critics say hospital price transparency proposal ‘misses the mark’
MDedge Hematology and Oncology
HHS proposes pathways for drug importation
MDedge Hematology and Oncology
Conflicts of interest common among authors of ASCO guidelines
MDedge Hematology and Oncology